Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D L Crosby

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Gastroenterology & Hepatology|December 18, 2017
Challenging disease, challenging trial, challenging interpretationThomas D L Crosby
International Journal of Radiation Oncology, Biology, Physics|August 23, 2008
Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapyMichael R Button, Carys A Morgan, Elizabeth S Croydon, et al.
Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Gastroenterology & Hepatology|December 18, 2017
Challenging disease, challenging trial, challenging interpretationThomas D L Crosby
International Journal of Radiation Oncology, Biology, Physics|August 23, 2008
Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapyMichael R Button, Carys A Morgan, Elizabeth S Croydon, et al.
Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
Pageof 1